Bio-Rad Laboratories Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $358.25
- Today's High:
- $363.44
- Open Price:
- $360.51
- 52W Low:
- $344.63
- 52W High:
- $572.7
- Prev. Close:
- $362.71
- Volume:
- 141139
Company Statistics
- Market Cap.:
- $10.91 billion
- Book Value:
- 329.76
- Revenue TTM:
- $2.78 billion
- Operating Margin TTM:
- 14.97%
- Gross Profit TTM:
- $1.57 billion
- Profit Margin:
- -6.88%
- Return on Assets TTM:
- 1.86%
- Return on Equity TTM:
- -1.92%
Company Profile
Bio-Rad Laboratories Inc had its IPO on 1966-01-01 under the ticker symbol BIO.
The company operates in the Healthcare sector and Medical Devices industry. Bio-Rad Laboratories Inc has a staff strength of 8,200 employees.
Stock update
Shares of Bio-Rad Laboratories Inc opened at $360.51 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $358.25 - $363.44, and closed at $361.95.
This is a -0.21% slip from the previous day's closing price.
A total volume of 141,139 shares were traded at the close of the day’s session.
In the last one week, shares of Bio-Rad Laboratories Inc have slipped by -8.27%.
Bio-Rad Laboratories Inc's Key Ratios
Bio-Rad Laboratories Inc has a market cap of $10.91 billion, indicating a price to book ratio of 1.5167 and a price to sales ratio of 4.4181.
In the last 12-months Bio-Rad Laboratories Inc’s revenue was $2.78 billion with a gross profit of $1.57 billion and an EBITDA of $555.52 million. The EBITDA ratio measures Bio-Rad Laboratories Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Bio-Rad Laboratories Inc’s operating margin was 14.97% while its return on assets stood at 1.86% with a return of equity of -1.92%.
In Q1, Bio-Rad Laboratories Inc’s quarterly earnings growth was a positive 197.8% while revenue growth was a negative 3.3%.
Bio-Rad Laboratories Inc’s PE and PEG Ratio
- Forward PE
- 28.0112
- Trailing PE
- 0
- PEG
- 1.0737
Its diluted EPS in the last 12-months stands at $-6.96 per share while it has a forward price to earnings multiple of 28.0112 and a PEG multiple of 1.0737. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bio-Rad Laboratories Inc’s profitability.
Bio-Rad Laboratories Inc stock is trading at a EV to sales ratio of 4.3577 and a EV to EBITDA ratio of -1.5907. Its price to sales ratio in the trailing 12-months stood at 4.4181.
Bio-Rad Laboratories Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $13.67 billion
- Total Liabilities
- $589.62 million
- Operating Cash Flow
- $-70473000.00
- Capital Expenditure
- $35.73 million
- Dividend Payout Ratio
- 0%
Bio-Rad Laboratories Inc ended 2024 with $13.67 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $13.67 billion while shareholder equity stood at $9.76 billion.
Bio-Rad Laboratories Inc ended 2024 with $1.77 billion in deferred long-term liabilities, $589.62 million in other current liabilities, 3000.00 in common stock, $9.97 billion in retained earnings and $407.76 million in goodwill. Its cash balance stood at $464.14 million and cash and short-term investments were $1.86 billion. The company’s total short-term debt was $519,000 while long-term debt stood at $1.20 billion.
Bio-Rad Laboratories Inc’s total current assets stands at $3.28 billion while long-term investments were $8.88 billion and short-term investments were $1.39 billion. Its net receivables were $498.27 million compared to accounts payable of $334.89 million and inventory worth $752.94 million.
In 2024, Bio-Rad Laboratories Inc's operating cash flow was $-70473000.00 while its capital expenditure stood at $35.73 million.
Comparatively, Bio-Rad Laboratories Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $361.95
- 52-Week High
- $572.7
- 52-Week Low
- $344.63
- Analyst Target Price
- $569.2
Bio-Rad Laboratories Inc stock is currently trading at $361.95 per share. It touched a 52-week high of $572.7 and a 52-week low of $572.7. Analysts tracking the stock have a 12-month average target price of $569.2.
Its 50-day moving average was $392.32 and 200-day moving average was $422.96 The short ratio stood at 1.35 indicating a short percent outstanding of 0%.
Around 1452.8% of the company’s stock are held by insiders while 7970.4% are held by institutions.
Frequently Asked Questions About Bio-Rad Laboratories Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.